AI assistant
Sending…
SERA PROGNOSTICS, INC. — Director's Dealing 2022
Jan 4, 2022
34084_dirs_2022-01-04_44aa73a0-e544-4e8d-a714-203be39fa46e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SERA PROGNOSTICS, INC. (SERA)
CIK: 0001534969
Period of Report: 2021-12-30
Reporting Person: Foley Michael R (Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.77 | 2030-08-20 | Class A Common Stock (9620.0) | Direct |
Footnotes
F1: These stock options vest over two years as follows: 1/24 of the original grant amount vests in monthly installments for two years following the vesting commencement date, which is May 18, 2020.
More from SERA PROGNOSTICS, INC.
Proxy Solicitation & Information Statement
2026
Jun 1
Board/Management Information
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 27
Major Shareholding Notification
2026
Jan 16
Regulatory Filings
2026
Jan 8
Regulatory Filings
2026
Jan 7